Literature DB >> 81509

Islet-cell antibodies (ICA) in diabetes mellitus (evidence of an autoantigen common to all cells in the islet of Langerhans).

G F Bottazzo, D Doniach.   

Abstract

Pancreatic islet-cell antibodies (ICA) are important markers for two subtypes of insulin-dependent diabetes mellitus and stain the entire islet in the standard immunofluorescence test. This could indicate either a mixture of antibodies each directed against one cell type, or a population of antibodies reacting with a single antigen common to the endocrine pancreas. In the present experiments such a common antigen was demonstrated visually by application of animal antisera raised to each of the 4 pancreatic hormones, together with ICA-positive sera in a four-layer double immunofluorescent technique employing green and red anti-Ig conjugates. Double exposure photographs demonstrated that the patients' sera reacted equally with the different endocrine cells. The ICA antigen did not cross-react with gastric glucagon- or somatostatin-cells. By contrast, human antibodies against glucagon-cells (GCA) or somatostatin-cells (SCA) reacted with discrete antigens specific to each cell type and in 50% of cases the antibodies also stained the respective endocrine cells in the gastrointestinal tract. These refined discriminatory properties of human autoantibodies may lead to a better understanding of the intracellular membrane systems in these important endocrine organs.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81509

Source DB:  PubMed          Journal:  Ric Clin Lab        ISSN: 0390-5748


  12 in total

Review 1.  Molecular mechanisms involved in the etiology and pathogenesis of autoimmune diseases.

Authors:  M Trucco
Journal:  Clin Investig       Date:  1992-09

2.  Beta-cell damage in diabetic insulitis: are we approaching a solution?

Authors:  G F Bottazzo
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

3.  Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility.

Authors:  F Sotsiou; G F Bottazzo; D Doniach
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

4.  Islet-cell antibodies and beta-cell function in insulin-dependent diabetics.

Authors:  S Madsbad; G F Bottazzo; A G Cudworth; B Dean; O K Faber; C Binder
Journal:  Diabetologia       Date:  1980-01       Impact factor: 10.122

5.  Presence of complement-dependent cytotoxic activity against clonally-derived rat islet tumour cells in sera from type 1 (insulin-dependent) diabetic patients and control subjects.

Authors:  D E Cavender; M A Virji; S Holze-Joost
Journal:  Diabetologia       Date:  1986-09       Impact factor: 10.122

6.  Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen.

Authors:  W Richter; J Endl; T H Eiermann; M Brandt; R Kientsch-Engel; C Thivolet; H Jungfer; W A Scherbaum
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

7.  Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies.

Authors:  W Richter; T H Eiermann; J Endl; J Seissler; S Wolfahrt; M Brandt; H Jungfer; W A Scherbaum
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

8.  Anti-pancreatic immunity. In vitro studies of cellular and humoral immune reactions directed toward pancreatic islets.

Authors:  C Boitard; P Saï; M Debray-Sachs; R Assan; J Hamburger
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

9.  Islet cell antibodies and diabetes mellitus in Pima Indians.

Authors:  W C Knowler; P H Bennett; G F Bottazzo; D Doniach
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

10.  Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Genovese; E Bonifacio; J M McNally; B M Dean; R Wagner; E Bosi; E A Gale; G F Bottazzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.